Recent advances in the understanding and management of mucormycosis
- PMID: 30271573
- PMCID: PMC6134337
- DOI: 10.12688/f1000research.15081.1
Recent advances in the understanding and management of mucormycosis
Abstract
Mucormycoses were difficult-to-manage infections owing to limited diagnostic tools and therapeutic options. We review here advances in pathology understanding, diagnostic tools including computed tomography, and serum polymerase chain reaction and therapeutic options.
Keywords: Isavuconazole; Liposomal amphotericin B; Mucormycosis; PCR; Reverse Halo sign.
Conflict of interest statement
Competing interests: FL is a speaker for bureau Gilead, Basilea, MSD. Concultancy Basilea. She received research grant from Gilead Sciences. OL has been a consultant for Gilead Sciences, a speakers’ bureau for Pfeizer, Novartis, Astellas, Merck, and Gilead Sciences, and has received research grants from Gilead Sciences. AA has received travel grant from MSD, Gilead and Astella and honoraria from Pathoquest and Gilead outside the submitted work. BP has no competing interests to declare.No competing interests were disclosed.No competing interests were disclosed.
Figures
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
